Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupesh Dash

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2011
Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicityRupesh Dash, Belal Azab, Bridget A Quinn, et al.
Expert Opinion on Investigational Drugs|August 20, 2011
Targeting Mcl-1 for the therapy of cancerBridget A Quinn, Rupesh Dash, Belal Azab, et al.
Molecular Omics|May 4, 2022
Long-read 16S-seq reveals nasopharynx microbial dysbiosis and enrichment of <i>Mycobacterium</i> and <i>Mycoplasma</i> in COVID-19 patients: a potential source of co-infectionPunit Prasad, Soumendu Mahapatra, Rasmita Mishra, et al.
Cytokine & Growth Factor Reviews|October 8, 2010
mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicityRupesh Dash, Sujit K Bhutia, Belal Azab, et al.
Pharmacology & Therapeutics|August 25, 2010
The development of MDA-7/IL-24 as a cancer therapeuticPaul Dent, Adly Yacoub, Hossein A Hamed, et al.
Frontiers in Cellular and Infection Microbiology|January 7, 2022
Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in IndiaSanchari Chatterjee, Ankita Datey, Soumya Sengupta, et al.
Frontiers in Microbiology|December 17, 2020
Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus InfectivitySunil Raghav, Arup Ghosh, Jyotirmayee Turuk, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 31, 2012
Selected approaches for rational drug design and high throughput screening to identify anti-cancer moleculesMichael Hedvat, Luni Emdad, Swadesh K Das, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2011
Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicityRupesh Dash, Belal Azab, Bridget A Quinn, et al.
Expert Opinion on Investigational Drugs|August 20, 2011
Targeting Mcl-1 for the therapy of cancerBridget A Quinn, Rupesh Dash, Belal Azab, et al.
Molecular Omics|May 4, 2022
Long-read 16S-seq reveals nasopharynx microbial dysbiosis and enrichment of <i>Mycobacterium</i> and <i>Mycoplasma</i> in COVID-19 patients: a potential source of co-infectionPunit Prasad, Soumendu Mahapatra, Rasmita Mishra, et al.
Cytokine & Growth Factor Reviews|October 8, 2010
mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicityRupesh Dash, Sujit K Bhutia, Belal Azab, et al.
Pharmacology & Therapeutics|August 25, 2010
The development of MDA-7/IL-24 as a cancer therapeuticPaul Dent, Adly Yacoub, Hossein A Hamed, et al.
Frontiers in Cellular and Infection Microbiology|January 7, 2022
Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in IndiaSanchari Chatterjee, Ankita Datey, Soumya Sengupta, et al.
Frontiers in Microbiology|December 17, 2020
Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus InfectivitySunil Raghav, Arup Ghosh, Jyotirmayee Turuk, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 31, 2012
Selected approaches for rational drug design and high throughput screening to identify anti-cancer moleculesMichael Hedvat, Luni Emdad, Swadesh K Das, et al.
Pageof 8